We are live on
!
Find out more
WP
Waycross Partners Portfolio holdings
AUM
$1.05B
1-Year Est. Return
20.92%
This Fund
S&P 500
This Quarter
Est. Return
+3.48%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$59.6M
(+5.1%)
Cap. Flow
+$26.8M
Cap. Flow
% of AUM
2.2%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
99
New
4
Increased
23
Reduced
10
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$30.7M |
| 2 |
Intuit
INTU
|
+$30M |
| 3 |
Procter & Gamble
PG
|
+$14.4M |
| 4 |
Mastercard
MA
|
+$5.74M |
| 5 |
MRSH
Marsh
MRSH
|
+$5.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$27.8M |
| 2 |
Southern Company
SO
|
+$14.4M |
| 3 |
Target
TGT
|
+$13.9M |
| 4 |
Broadcom
AVGO
|
+$8.45M |
| 5 |
Goldman Sachs
GS
|
+$5.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.04% |
| 2 | Financials | 15.36% |
| 3 | Industrials | 12.27% |
| 4 | Communication Services | 11.54% |
| 5 | Consumer Discretionary | 9.32% |
Similar funds
RC
LPC
ANBT
HWCM
AA
AAIM
CIA
TPWA
Waycross Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Waycross Partners held 99 positions worth $1.22B, up 5.1% from $1.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Waycross Partners's Q4 2025 filing shows 4 new, 23 increased, 10 reduced and 5 closed positions. Its largest new stake was Sherwin-Williams: 91,796 shares worth $29.7M. The largest sale was Idexx Laboratories, an estimated $27.8M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Industrials.
- Waycross Partners's largest Q4 2025 buy was Sherwin-Williams: 91,796 shares worth $29.7M.
- Waycross Partners added most to Procter & Gamble in Q4 2025, an estimated $14.4M increase.
- Waycross Partners's biggest Q4 2025 reduction was Southern Company, cutting an estimated $14.4M.
- Waycross Partners fully exited Idexx Laboratories in Q4 2025, selling an estimated $27.8M.
- Waycross Partners's ten largest holdings make up 50% of its $1.22B portfolio in Q4 2025.
- Waycross Partners opened 4 new positions and closed 5 in Q4 2025.
- Waycross Partners's portfolio value rose 5.1% quarter-over-quarter to $1.22B.
Based on Waycross Partners's 13F filing for Q4 2025, filed 14 Jan 2026.